Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

Recent studies demonstrate an increased risk of second primary malignancies (SPM) in multiple myeloma (MM) patients on maintenance lenalidomide following autologous stem cell transplantation (ASCT). There may be other risk factors driving SPM post-ASCT in MM, so we explored this possibility through...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krishnan, Amrita Y., Mei, Matthew, Sun, Can-Lan, Thomas, Sandra H., Berano Teh, Jennifer, Kang, Tongjun, Htut, Myo, Somlo, George, Sahebi, Firoozeh, Forman, Stephen J., Bhatia, Smita
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553262/
https://ncbi.nlm.nih.gov/pubmed/23073267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.09.023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados